Insulet (FRA:GOV) Total Operating Expense : €903 Mil (TTM As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Insulet Total Operating Expense?

Insulet's Total Operating Expense for the three months ended in Mar. 2024 was €230 Mil. Insulet's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was €903 Mil.

Insulet Total Operating Expense Historical Data

The historical data trend for Insulet's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Insulet Total Operating Expense Chart

Insulet Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Operating Expense

Get a 7-Day Free Trial

387.27

436.32

554.10

724.99

861.89

Insulet Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Operating Expense	Get a 7-Day Free Trial															198.76	215.80	223.47	233.65	229.91

Insulet Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €903 Mil.

Insulet Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Insulet's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Insulet (FRA:GOV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Insulet Corp (FRA:GOV) » Definitions » Total Operating Expense

Comparable Companies

Traded in Other Exchanges

PODD:USA PODD:Mexico

Address

100 Nagog Park, Acton, MA, USA, 01720

Website

https://www.insulet.com

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 360,000 insulin-dependent diabetics are using it worldwide.

Insulet (FRA:GOV) Headlines

No Headlines